Shavit Capital Fund

About The Fund

Shavit Capital is a private equity firm focused on late-stage investments, primarily in Israeli and Israeli-related companies. Established in 2008, the firm manages over $400 million across five separate funds, with the fifth fund raised in 2019. Shavit Capital specializes in equity investments with a minimum investment threshold of $15 million. They target companies that possess proven technologies, products, markets, and robust management teams, preparing these companies for significant financial events such as initial public offerings (IPOs) on major international public exchanges or dual listings on the Tel Aviv Stock Exchange. Shavit Capital’s investment expertise extends to mezzanine or bridge rounds, facilitating subsequent larger capital raises for their portfolio companies. Additionally, they actively engage in Private Investment in Public Equities (PIPEs) involving publicly-traded Israeli companies. The fund is characterized by its strong knowledge base and venture capital (VC) approach, with a specialty in expansion-stage financing, management buyouts/leveraged buyouts (MBO/LBO), and various series financing rounds ranging from Series A to pre-IPO stages. Shavit Capital has a pronounced expertise in various industries, notably BioTech, Hardware and Manufacturing, and Medical Devices and Hospital Services. Their headquarters are strategically located at 1700 Seventh Avenue, Suite 2300, Seattle, Washington, 98101, United States, enabling them to leverage their geographical presence to foster growth within their target investments. The firm’s strategic focus and financial stewardship are aimed at achieving substantial growth and fostering innovation within their chosen markets.